Wall Street’s Bounty Hunter Abandons Short Selling Research
- Citron’s Andrew Left says he plans long-only recommendations
- Left clashed with an army of day traders supporting GameStop
This article is for subscribers only.
The bounty hunter of Wall Street has finally met his match.
Andrew Left, who’s taken on everything from drug companies to Chinese real estate firms, said his Citron Research will no longer publish short selling research, ending the firm’s two-decade run as one of Wall Street’s best-known contrarians.